Status:
UNKNOWN
Antibiotic Prophylaxis and Nausea and Vomiting in Cesarean Section Under Regional Anesthesia.
Lead Sponsor:
Baskent University Ankara Hospital
Conditions:
Intraoperative Nausea-retching-vomiting Episodes
Nausea Scores Will be Evaluated on the Verbal Analog Scale (VAS)
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
The incidence of intraoperative nausea and vomiting in patients who undergo caesarean section (C/S) under regional anesthesia is approximately 30-80%. Hypotension, pain, visceral manipulation, fundal ...
Eligibility Criteria
Inclusion
- Pregnant women (≥ 37 gestational weeks) undergoing elective C/S under regional anesthesia
Exclusion
- Emergency C/S cases
- Patients who had nausea before C/S
- Patients who used antiemetics within 24 hours before C/S
- Patients who have a history of smoking, postoperative nausea-vomiting, motion sickness, and hyperemesis before C/S
- Patients with history of diabetes, morbid obesity (Body Mass Index\> 40) and gastrointestinal disease
- Psychiatric disorders
- Patients who are allergic to the drugs to be used in the study
- Patients for whom regional anesthesia is contraindicated
Key Trial Info
Start Date :
August 20 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04697277
Start Date
August 20 2015
End Date
May 30 2021
Last Update
January 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baskent University
Ankara, Turkey (Türkiye)